Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.9 billion and currently trading near $31,
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-01-23 01:26:47